Innoviva Earnings
NASDAQ: INVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.49
Innoviva earnings summary
Innoviva is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.49. In its most recent report on Aug 5, 2026 (Q2 2026), INVA posted EPS of $-1.14. Revenue for the quarter was $119.6 million.
Quarterly EPS is down 248.1% from the same quarter a year earlier. Across the last 16 reports, INVA shares moved an average of 3.7% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
INVA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-1.14 | — | +3.3% |
| May 6, 2026 | — | $2.22 | — | -4.0% |
| Feb 25, 2026 | — | $2.19 | — | -4.1% |
| Nov 5, 2025 | — | $1.08 | — | +6.7% |
| Aug 6, 2025 | — | $0.77 | — | +14.1% |
| May 7, 2025 | — | $-0.74 | — | +0.1% |
| Feb 26, 2025 | — | $0.43 | — | -1.6% |
| Nov 6, 2024 | — | $0.02 | — | -6.3% |
| Jul 31, 2024 | — | $-0.55 | — | -4.2% |
| May 8, 2024 | — | $0.46 | — | +2.4% |
| Feb 29, 2024 | — | $0.78 | — | -2.6% |
| Nov 1, 2023 | — | $0.98 | — | -1.2% |
| Aug 2, 2023 | — | $0.02 | — | -0.5% |
| May 9, 2023 | — | $0.42 | — | +6.3% |
| Feb 28, 2023 | — | $-0.68 | — | -1.8% |
| Nov 9, 2022 | — | $2.80 | — | -0.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.